CAR- T and cellular gene treatments are actually also expensive

.Nature Medicine, Released online: 04 September 2024 doi:10.1038/ s41591-024-03231-zPoint-of-care production and technology transmission may supply mobile genetics therapies at an inexpensive expense to people all over the world.